COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19

Reports of collapsing glomerulopathy in patients of African ancestry and high-riskAPOL1genotype infected with SARS-CoV-2 have emerged during the COVID-19 pandemic. This new entity, which we term COVID-19-associated nephropathy (COVAN), may particularly impact individuals in some regions of the world. Awareness of this potentially ominous complication of COVID-19 must be raised.